About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETEDPhase 1/2

Immunotherapy With Vacc-C5 With Adjuvant GM-CSF or Alhydrogel in HIV-1-infected Subjects on ART

Immunotherapy of HIV-infected Patients An Open, Dose-escalating Assessment of Vacc-C5 With Either GM-CSF or Alhydrogel as Adjuvant in HIV-1-infected Subjects on Antiretroviral Therapy (ART)

NCT01627678•Bionor Immuno AS

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

HIV-1 Infection

Interventions

Vacc-C5/GM-CSF

Vacc-C5/Alhydrogel

Locations

1

Norway

Locations (1)

Oslo University Hospital, Ullevål

Oslo, Norway

Key Dates

Start Date

September 1, 2012

Primary Completion Date

November 1, 2013

Completion Date

November 1, 2013

Last Updated

January 14, 2014

Related Studies

RECRUITINGPhase 4

Change in Body Weight and BMI in PWH with DOR/3TC/TDF Compared with INSTI

NCT06602622

HIVHIV Associate Weight Loss+4 more

COMPLETEDPhase 4

Implementation of Out-of-HOspital Administration of the Long-Acting Cabotegravir+Rilpivirine

NCT06185452

HIV-1 Infection

Not Yet RecruitingNA

Clinical Research on the Use of Immune Checkpoint Inhibitors Combined With Chidamide for the Functional Cure of AIDS

NCT06902038

HIV-1 Infection

Study to Assess the ART Impact on the Brain Outcomes. The ARBRE Study

NCT03835546

HIV-1 InfectionCognitive Impairment

COMPLETEDPhase 1

Study to Evaluate Effects of Vorinostat and HXTC on Persistent HIV-1 Infection in HIV-Infected Subjects Started on Antiretroviral Therapy (ART)

NCT03212989

HIV-1 Infection

COMPLETEDPhase 1

Study for Evaluation of the Safety, Pharmacokinetics, and Antiviral Activity of UB-421 Subcutaneous Formulation Administered in HIV-1 Infected Treatment Naive Patients

NCT04620304

HIV-1 Infection

View all related studies

Sponsors

Lead Sponsor

Bionor Immuno AS

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 14, 2014Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions